What StemCyte does and who owns it

StemCyte is a private cord blood bank owned by Cryo-Cell International, a publicly traded company. The bank collects, processes, and stores umbilical cord blood stem cells for families who want to preserve them for potential future medical use. StemCyte operates facilities in the United States and internationally, and it is one of the larger private cord blood banking companies by volume of samples stored.

The company processes cord blood using a method called volume reduction, which concentrates the stem cells and removes plasma and red blood cells before freezing. This approach reduces the storage space needed and may affect how the sample performs if it is ever used. StemCyte stores samples in liquid nitrogen at minus 196 degrees Celsius in multiple locations, including facilities in California and Arizona.

As a private bank, StemCyte charges families an upfront collection and processing fee, then annual storage fees for as long as the sample remains frozen. The company does not receive government funding and does not contribute samples to public registries, so the cord blood is reserved exclusively for the family who paid for it or for a directed donation to a relative if the family chooses that option.

Key Takeaways

  • StemCyte is a private cord blood bank that charges an initial processing fee and ongoing annual storage costs, with no public funding involved.
  • The company uses volume reduction processing, which concentrates stem cells but differs from the methods used by some other private banks and public banks.
  • Samples are stored in liquid nitrogen at multiple U.S. facilities and remain the property of the family that paid for banking.
  • StemCyte does not currently operate as a public bank, so samples are not available to patients outside the family unless the family directs a donation to a relative.
  • The company has been in operation since the 1990s and is part of Cryo-Cell International, a company traded on the NASDAQ stock exchange.

How StemCyte's processing method compares to other banks

StemCyte uses volume reduction to process cord blood, a technique that removes much of the liquid portion of the sample and concentrates the stem cells into a smaller volume. This reduces storage space and cost, but it also means the final product is different from what you would receive from a bank using other processing methods. Some families choose volume reduction because it lowers long-term storage fees; others avoid it because the concentrated sample may not perform identically to unprocessed or differently processed cord blood if it is thawed and used.

Public cord blood banks and some private banks use different processing approaches. The National Marrow Donor Program (NMDP), which runs the largest public cord blood bank network in the United States, typically uses methods that preserve more of the original sample structure. Other private banks offer processing options that let families choose between volume reduction and other methods, or they may use a single standard approach. Before choosing a bank, ask what processing method it uses and whether research supports that method for the type of cells being stored.

StemCyte's storage locations and redundancy

StemCyte maintains cord blood samples in multiple facilities across the United States. The company stores samples in liquid nitrogen tanks at locations including California and Arizona. Storing samples in more than one location provides some protection against loss from a single facility failure, such as equipment malfunction or natural disaster, though no storage system is risk-free.

The company has experienced storage incidents in the past. In 2012, StemCyte reported that approximately 2,000 samples were damaged due to a storage tank failure at one of its facilities. The incident raised questions about backup systems and monitoring. Since then, the company has stated it has upgraded its monitoring and backup procedures, but families considering StemCyte should understand that cord blood banking carries inherent risks, and no bank can may provide a sample will remain viable indefinitely or that it will be usable if thawed.

Costs and what families pay over time

StemCyte charges an initial collection and processing fee that varies depending on the specific service package chosen. The company also charges annual storage fees that continue for as long as the sample is kept frozen. The exact amounts change over time and may differ based on promotions or payment plans the company offers, so you would need to contact StemCyte directly for current pricing.

When comparing private banks, consider the total cost over 18 to 21 years, which is the age range at which many families might want to use a stored sample. A bank with a lower initial fee but higher annual storage costs may end up costing more than one with a higher upfront fee and lower yearly charges. Some private banks offer payment plans or discounts for upfront payment of multiple years of storage. Ask StemCyte whether it offers such options and whether fees are locked in or subject to increase.

What happens to your sample if StemCyte closes

If a private cord blood bank closes or goes out of business, families with stored samples face the risk of losing access to them. The cord blood banking industry is not heavily regulated at the federal level, and there is no requirement that a bank maintain a fund to relocate samples if it fails. Some states have enacted laws requiring banks to have a plan for sample transfer or disposal, but these protections vary widely.

StemCyte is part of Cryo-Cell International, a company with a long operating history, which may suggest greater stability than a smaller, newer bank. However, no private company is may provide to remain in business indefinitely. Before banking with any private provider, ask what would happen to your sample if the company closed, whether there is a contractual may provide of sample transfer, and whether the company has insurance or reserves set aside for this scenario. Get the answer in writing as part of your banking agreement.

Private banking versus public banking through StemCyte

StemCyte operates only as a private bank, meaning families pay to store their child's cord blood for their own use. The company does not operate a public banking program where samples are donated for use by any patient who needs them. If you want your child's cord blood available to the general public through a public registry, you would need to bank with a public cord blood bank instead, such as one of the programs run by the NMDP or other public banking networks.

The choice between private and public banking depends on your goals. Private banking reserves the sample for your family and gives you control over its use, but you pay all costs and the sample may never be used. Public banking is free to families, but the sample becomes the property of the public bank and may be used by any patient who matches it. Some families choose to do both: bank privately with StemCyte and also donate to a public bank, though this requires collecting enough cord blood for both purposes, which is not always possible.

Directed donations to relatives through StemCyte

StemCyte allows families to designate a sample for directed donation to a relative, such as a sibling with a known genetic condition that might benefit from stem cell therapy. In this case, the family still pays for collection and storage, but the sample is reserved for that specific relative rather than for the child born. Directed donation can be a middle ground between private banking (which reserves the sample only for the original child) and public banking (which makes it available to anyone).

If you are considering directed donation, discuss with StemCyte what documentation is required, how the relative's medical condition is evaluated, and what happens to the sample if the relative does not need it or if circumstances change. Also ask whether the relative would have any legal claim to the sample or whether the family retains ownership and control.

Frequently Asked Questions

Is StemCyte accredited or regulated by the FDA?

StemCyte operates under FDA oversight as a facility that processes and stores human cells, but the FDA does not formally accredit cord blood banks. The company follows FDA regulations for cell processing and storage. Some private banks pursue accreditation from the American Association of Blood Banks (AABB), which sets standards for collection, processing, and storage. Check StemCyte's website or contact the company directly to learn whether it holds AABB accreditation or other third-party certifications.

Can I use my StemCyte sample if I move to another country?

StemCyte stores samples in the United States, so if you move abroad, you would need to arrange transport of the sample or work with the company on options for access. International transport of biological samples is heavily regulated and expensive. Before banking with StemCyte, ask about procedures for sample retrieval or transfer if you relocate outside the U.S., and get the answer in your banking contract.

What medical conditions can cord blood stem cells treat right now?

Cord blood stem cells are currently used to treat a limited number of blood disorders and cancers, primarily through bone marrow transplant procedures. These include certain leukemias, lymphomas, and inherited blood disorders. Most other uses, such as treatment for cerebral palsy or autism, remain experimental and are not standard medical practice. Before banking, research the current clinical uses of cord blood and understand that the sample may never be used for any condition.

What is the difference between StemCyte's volume reduction and other processing methods?

Volume reduction concentrates stem cells by removing plasma and red blood cells, resulting in a smaller final product. Other methods preserve more of the original sample structure. Research on which method produces better outcomes is ongoing, and no single method is proven superior for all uses. Ask StemCyte for published research supporting its processing approach and compare it to research on other methods before deciding.

If I bank with StemCyte, can I change my mind and get my money back?

Refund policies vary by private bank and by the specific contract you sign. Some banks offer a money-back may provide within a certain window (such as 30 days), while others do not. Review StemCyte's refund policy carefully before signing any agreement, and ask whether the policy covers the full amount paid or only a portion of it.